Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling

Clinical Cancer Research

Volumn 14, Issue 1, 2008, Pages 74-81

  Yang, Yan Hong ^a   Deng, Hua ^a   Li, Wen Mei ^a   Zhang, Qing Yun ^a   Hu, Xiao Ting ^a   Xiao, Bai ^b   Zhu, Hai Hong ^c   Geng, Pai Li ^c   Lu, You Yong ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Qinghai Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; STROMELYSIN 3; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RESEARCH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE ISOLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONLINE ANALYSIS; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; STOMACH CANCER; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE, TUMOR; DATABASES, GENETIC; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LIBRARY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 11; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 40749156709     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1179     Document Type: Article

References (36)

1. Alex EL, Carolyn MT, Lukas W, Gregory DS, Robert LS, Gregory J. SAGEmap: a public gene expression resource. Genome Res 2000;10:1051-60.
2. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995;270:484-7.
3. Zhang L, Zhou W, Victor EV, et al. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-78.
4. Colleen DH, Cheryl AS, Ellen SP, et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000;60:6281-7.
5. Guelaguetza V, Patricia P, Karla V, et al. Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 2005;5:68.
6. Joji I, Krista LW, Matthew AP, et al. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 2004;122:167-76.
7. Bassett P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
8. Pei DQ, Gopa M, Stephen JW. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 1994;269:25849-55.
9. Agnès N, Maria S, Isabelle S, et al. Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J Biol Chem 1995;270:22866-72.
10. Anne MD, Ernesto C. Dual regulation of Stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts. J Biol Chem 1998;273:16595-600.
11. Deng H, Guo RF, Li WM, Zhao M, Lu YY. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. Biochem Biophys Res Commun 2005;326:274-81.
12. Deng GR, Lu YY, Chen SM, et al. Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res 1987;47:3195-8.
13. Li Y, Lu YY. Isolation of diallyl trisulfide inducible differentially expressed genes in human gastric cancer cells by modified cDNA representational difference analysis. DNA Cell Biol 2002;21:771-80.
14. Tang ZB, Zhao M, Ji JF, et al. Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia. Oncol Rep 2004;11:333-9.
15. Pei DQ. Matrix metalloproteinases target protease-activated receptors on the tumor cell surface. Cancer Cell 2005;7:207-8.
16. Santos M, Emilia M, Maria M, et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997;272:25706-12.
17. Honkavuori M, Talvensaari MA, Soini Y, Turpeenniemi HT, Santala M. MMP-2 expression associates with CA125 and clinical course in endometrial carcinoma. Gynecol Oncol 2007;104:217-21.
18. Ogawa M, Ikeuchi K, Watanabe M, et al. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterology 2005;52:875-80.
19. Zheng H, Takahashi H, Murai Y, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006;26:3579-83.
20. Wu CY, Wu MS, Chiang EP, et al. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res 2007;13:2054-60.
21. Mylona E, Nomikos A, Magkou C, et al. The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma. Histopathology 2007;50:338-47.
22. Shilpi A, Jatinder K, Chavvi S, et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005;6:2272-84.
23. Soni S, Mathur M, Shukla NK, Deo SV, Ralhan R. Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003;107:309-16.
24. Denys H, De WO, Nusgens B, et al. Invasion and MMP expression profile in desmoid tumours. Br J Cancer 2004;90:1443-9.
25. Kettunen E, Anttila S, Seppanen JK, et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 2004;149:98-106.
26. Hourihan RN, O'Sullivan GC, Morgan JG. Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 2003;23:161-5.
27. Boulay A, Masson R, Chenard MP, et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 2001;61:2189-93.
28. Andarawewa KL, Boulay A, Masson R, et al. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression. Cancer Res 2003;63:5844-9.
29. De Young MP, Damania H, Scheurle D, Zylberberg C, Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In Vivo 2002;16:239-48.
30. Michaël P, Pascal P, Marie PB, Nicole P, Jean PA, Isabelle VS. Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells, identification and regulation of a distal promoter. J Biol Chem 2001;276:15386-96.
31. Jiang XJ, Kim HE, Shu HJ, et al. Distinctive roles of PHAP proteins and prothymosin-α in a death regulatory pathway. Science 2003;10:223-6.
32. Raquel A, Elisabete S, Filipe S, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastricc arcinomas. J Pathol 2003;199:36-40.
33. Kirikoshi H, Sekihara H, Katoh M. Molecular cloning and characterization of human WNT7B. Int J Oncol 2001;19:779-83.
34. Wiksten JP, Lundin J, Nordling S, Kokkola A, Haglund C. A prognostic value of syndecan-1 in gastric cancer. Anticancer Res 2000;20:4905-7.
35. Wang JY, Chang CT, Hsieh JS, et al. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. J Surg Oncol 2003;83:253-60.
36. Nam ES, Kim DH, Cho SJ, et al. Expression of HMGI (Y) associated with malignant phenotype of human gastrict issue. Histopathology 2003;42:466-71.